ISSN:
1432-0711
Schlagwort(e):
Radioimmunoscintigraphy
;
Ovarian cancer
;
Monoclonal antibodies
Quelle:
Springer Online Journal Archives 1860-2000
Thema:
Medizin
Notizen:
Summary This article presents the state of the art of immunoscintigraphy (IS) of ovarian cancer. We will review the monoclonal antibodies (MoAbs) used in clinical trials: (HMFG1/2, OC125, H317, H17E2, NDOG2 and 791T/36). We conclude that none of the afore mentioned MoAbs are clearly superior and that IS cannot yet replace laparotomy for the diagnosis of overian cancer but may have a role in the follow-up of ovarian cancer, in timing second-look surgery and assessing the response/TD treatment.
Materialart:
Digitale Medien
URL:
http://dx.doi.org/10.1007/BF02390857
Permalink